$300+ Bn Contract Development and Manufacturing Organization (CDMO) Markets - Global Analysis & Forecast Report 2021-2026 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Global Contract Development and Manufacturing Organization (CDMO) Market Report and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.
Global contract development and manufacturing organization (CDMO) market attained a value of USD 177.1 billion in 2020. Aided by the rising demand for pharmaceutical products, the market is projected to further grow at a CAGR of 8.4% between 2021 and 2026 to reach a value of USD 302 billion by 2026.
The term contract development and manufacturing organization or CDMO refers to an entity that provides services to other pharmaceutical firms including drug development and marketing. The CDMO works on a contractual basis with pharmaceutical companies to help them outsource operations like those that can increase their market size as well as clinical research.
The expanding pharmaceutical sector will augment the demand for the contract development and manufacturing organization outsourcing market. To meet the high-volume demand for medications, pharma and biotech companies must have the manufacturing capacity to deliver the projected quantity while maintaining quality levels at a low cost.
Through the optimization of the supply chain and the enhancement of pharmaceutical companies' marketing capacities, the CDMO industry has been able to offer novel and effective pharmaceuticals to the market. This is increasing demand for the CDMO market. The growing global population is accompanied with an increase in acute and chronic diseases.
People's disposable income has increased as their understanding of healthcare has grown. This is fueling the market need for pharmaceutical items, resulting in the rapid rise of the CDMO industry. The increased investment of the industry in drug research and development and production is propelling the industry demand.
The North American market is one of the leading industries for contract development and manufacturing organizations (CDMO). This is due to the region's active CDMO key players, who are expanding partnerships and offering different service features. Because of the large workforce with high capabilities and the reduced cost advantage in R&D and production, Asia Pacific is projected to see substantial growth in CDMO.
The CDMO industry in this region has also benefited from government regulations and an increased emphasis on off-patent medications.
The report looks into the market shares, plant turnarounds, capacities, investments, and mergers and acquisitions, among other major developments, of the key players in the industry.
Some of the major players in the market explored in the report are:
- Lonza Group Ltd
- Catalent, Inc.
- Thermo Fisher Scientific, Inc.
- Jubilant Pharmova Ltd
- Aenova Holding GmbH
- Boehringer Ingelheim International GmbH
- Pfizer Inc.
- CordenPharma GmbH
- Recipharm AB
- Siegfried Holding AG
- Albany Molecular Research Inc.
- Fabbrica Italiana Sintetici S.p.A
- Fareva SA
Key Topics Covered:
2 Report Coverage - Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
7 Industry Opportunities and Challenges
8 Global Contract Development and Manufacturing Organization (CDMO) Market Analysis
8.1 Key Industry Highlights
8.2 Global Contract Development and Manufacturing Organization (CDMO) Historical Market (2016-2020)
8.3 Global Contract Development and Manufacturing Organization (CDMO) Market Forecast (2021-2026)
8.4 Global Contract Development and Manufacturing Organization (CDMO) Market by Service
8.5 Global Contract Development and Manufacturing Organization (CDMO) Market by CMO
8.6 Global Contract Development and Manufacturing Organization (CDMO) Market by CRO
8.7 Global Contract Development and Manufacturing Organization (CDMO) Market by Region
9 Regional Analysis
9.1 North America
9.3 Asia Pacific
9.4 Latin America
9.5 Middle East and Africa
10 Market Dynamics
10.1 SWOT Analysis
10.2 Porter's Five Forces Analysis
10.3 EMR's Key Indicators for Demand
10.4 EMR's Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
13 Industry Events and Developments
For more information about this report visit https://www.researchandmarkets.com/r/iqmgq2
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900